detected elevated levels of sCD25 in FHL patients, if compared to secondary HLH samples, but they observed poor correlation with another marker of T cell activation, HLA-DR expression on CD4+ and CD8+cells (72). This evidence concerns the gene CD4 and hemophagocytic syndrome.